Search results
Results from the WOW.Com Content Network
As of 2018, IDSA had more than 11,000 members from across the United States and nearly 100 other countries on six different continents. [2] IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
The U.S. Government Antimicrobial Resistance (AMR) Challenge, initiated in 2018, is a global effort that calls upon pharmaceutical and health insurance companies, food animal producers and purchasers, medical professionals, government health officials, and industry leaders worldwide to collaborate in combating antibiotic resistance.
Open Forum Infectious Diseases (OFID) is a peer-reviewed open-access scientific journal focusing on the field of infectious disease.It is operated by the Infectious Diseases Society of America (IDSA) and HIV Medicine Association and published online-only by Oxford University Press.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) is a scientific committee for defining guidelines to interpret antimicrobial resistance. [1] It was formed in 1997 and is jointly organized by ESCMID , ECDC and other European laboratories.
For the desired antimicrobial use, goals need to be formulated: Define "appropriate", rational antimicrobial use for the institution, individual patient units, and define empiric treatment versus culture-directed antimicrobial treatment. [citation needed] Establish treatment guidelines for clinical syndromes.
The diagnosis of vancomycin-resistant Staphylococcus aureus (VRSA) is performed by performing susceptibility testing on a single S. aureus isolate to vancomycin. This is accomplished by first assessing the isolate's minimum inhibitory concentration (MIC) using standard laboratory methods, including disc diffusion, gradient strip diffusion, and automated antimicrobial susceptibility testing ...
Antibiotic sensitivity testing is also conducted at a population level in some countries as a form of screening. [4] This is to assess the background rates of resistance to antibiotics (for example with methicillin-resistant Staphylococcus aureus ), and may influence guidelines and public health measures.
Outpatient parenteral antibiotic therapy (OPAT) is used to administer non-oral antibiotics (usually intravenously) without the need for ongoing hospitalisation. OPAT is particularly useful for people who are not severely ill but do require a prolonged course of treatment that cannot be given in oral form. [ 1 ]